vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Revolve Group, Inc.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.0倍（$324.4M vs $321.1M），Revolve Group, Inc.净利率更高（5.7% vs -18.2%，领先24.0%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 10.4%），Revolve Group, Inc.自由现金流更多（$-13.3M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
MDGL vs RVLV — 直观对比
营收规模更大
RVLV
是对方的1.0倍
$321.1M
营收增速更快
MDGL
高出200.3%
10.4%
净利率更高
RVLV
高出24.0%
-18.2%
自由现金流更多
RVLV
多$120.6M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $324.4M |
| 净利润 | $-58.6M | $18.6M |
| 毛利率 | — | 53.3% |
| 营业利润率 | -18.6% | 6.3% |
| 净利率 | -18.2% | 5.7% |
| 营收同比 | 210.8% | 10.4% |
| 净利润同比 | 1.4% | 50.4% |
| 每股收益（稀释后） | $-2.55 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLRVLV
| Q4 25 | $321.1M | $324.4M | ||
| Q3 25 | $287.3M | $295.6M | ||
| Q2 25 | $212.8M | $309.0M | ||
| Q1 25 | $137.3M | $296.7M | ||
| Q4 24 | $103.3M | $293.7M | ||
| Q3 24 | $62.2M | $283.1M | ||
| Q2 24 | — | $282.5M | ||
| Q1 24 | $0 | $270.6M |
净利润MDGLRVLV
| Q4 25 | $-58.6M | $18.6M | ||
| Q3 25 | $-114.2M | $21.2M | ||
| Q2 25 | $-42.3M | $10.2M | ||
| Q1 25 | $-73.2M | $11.8M | ||
| Q4 24 | $-59.4M | $12.3M | ||
| Q3 24 | $-107.0M | $11.0M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | $-147.5M | $10.9M |
毛利率MDGLRVLV
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | 96.7% | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
营业利润率MDGLRVLV
| Q4 25 | -18.6% | 6.3% | ||
| Q3 25 | -39.7% | 7.1% | ||
| Q2 25 | -22.2% | 5.8% | ||
| Q1 25 | -57.8% | 5.0% | ||
| Q4 24 | -64.8% | 3.9% | ||
| Q3 24 | -187.1% | 5.0% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | 3.4% |
净利率MDGLRVLV
| Q4 25 | -18.2% | 5.7% | ||
| Q3 25 | -39.8% | 7.2% | ||
| Q2 25 | -19.9% | 3.3% | ||
| Q1 25 | -53.4% | 4.0% | ||
| Q4 24 | -57.5% | 4.2% | ||
| Q3 24 | -172.0% | 3.9% | ||
| Q2 24 | — | 5.4% | ||
| Q1 24 | — | 4.0% |
每股收益（稀释后）MDGLRVLV
| Q4 25 | $-2.55 | $0.27 | ||
| Q3 25 | $-5.08 | $0.29 | ||
| Q2 25 | $-1.90 | $0.14 | ||
| Q1 25 | $-3.32 | $0.16 | ||
| Q4 24 | $-2.50 | $0.18 | ||
| Q3 24 | $-4.92 | $0.15 | ||
| Q2 24 | — | $0.21 | ||
| Q1 24 | $-7.38 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $292.3M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $512.5M |
| 总资产 | $1.3B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLRVLV
| Q4 25 | $198.7M | $292.3M | ||
| Q3 25 | $295.7M | $315.4M | ||
| Q2 25 | $186.2M | $310.7M | ||
| Q1 25 | $183.6M | $300.8M | ||
| Q4 24 | $100.0M | $256.6M | ||
| Q3 24 | $232.7M | $252.8M | ||
| Q2 24 | — | $244.7M | ||
| Q1 24 | $622.5M | $273.4M |
总债务MDGLRVLV
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益MDGLRVLV
| Q4 25 | $602.7M | $512.5M | ||
| Q3 25 | $625.7M | $490.2M | ||
| Q2 25 | $696.0M | $468.6M | ||
| Q1 25 | $710.6M | $453.4M | ||
| Q4 24 | $754.4M | $437.8M | ||
| Q3 24 | $777.2M | $420.8M | ||
| Q2 24 | — | $405.8M | ||
| Q1 24 | $850.8M | $389.9M |
总资产MDGLRVLV
| Q4 25 | $1.3B | $765.0M | ||
| Q3 25 | $1.4B | $751.3M | ||
| Q2 25 | $1.0B | $722.9M | ||
| Q1 25 | $996.6M | $713.9M | ||
| Q4 24 | $1.0B | $665.5M | ||
| Q3 24 | $1.1B | $670.9M | ||
| Q2 24 | — | $657.8M | ||
| Q1 24 | $1.1B | $650.0M |
负债/权益比MDGLRVLV
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $-13.3M |
| 自由现金流率自由现金流/营收 | -41.7% | -4.1% |
| 资本支出强度资本支出/营收 | 0.1% | 1.0% |
| 现金转化率经营现金流/净利润 | — | -0.55× |
| 过去12个月自由现金流最近4个季度 | — | $48.0M |
8季度趋势，按日历期对齐
经营现金流MDGLRVLV
| Q4 25 | $-133.5M | $-10.2M | ||
| Q3 25 | $79.8M | $11.8M | ||
| Q2 25 | $-47.1M | $12.6M | ||
| Q1 25 | $-88.9M | $45.1M | ||
| Q4 24 | $-104.5M | $3.9M | ||
| Q3 24 | $-67.0M | $9.1M | ||
| Q2 24 | — | $-24.7M | ||
| Q1 24 | $-149.2M | $38.4M |
自由现金流MDGLRVLV
| Q4 25 | $-133.8M | $-13.3M | ||
| Q3 25 | $79.0M | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | $-104.7M | $2.1M | ||
| Q3 24 | $-67.8M | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | $-149.5M | $36.7M |
自由现金流率MDGLRVLV
| Q4 25 | -41.7% | -4.1% | ||
| Q3 25 | 27.5% | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | -101.3% | 0.7% | ||
| Q3 24 | -109.0% | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度MDGLRVLV
| Q4 25 | 0.1% | 1.0% | ||
| Q3 25 | 0.3% | 1.5% | ||
| Q2 25 | 0.0% | 0.7% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 1.3% | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
现金转化率MDGLRVLV
| Q4 25 | — | -0.55× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
